Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Junsaku Nagaoka is active.

Publication


Featured researches published by Junsaku Nagaoka.


Bioorganic & Medicinal Chemistry | 2001

2-Alkynyl-8-aryladenines possessing an amide moiety: their synthesis and structure–activity relationships of effects on hepatic glucose production induced via agonism of the A2B adenosine receptor

Hitoshi Harada; Osamu Asano; Tsutomu Kawata; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Kaya Nagata; Manabu Murakami; Junsaku Nagaoka; Seiichi Kobayashi; Isao Tanaka; Shinya Abe

A series of 2-alkynyl-8-aryladenine derivatives bearing an amide moiety at the 9-position of adenine was synthesized. These analogues were evaluated for inhibitory activity on N-ethylcarboxamidoadenosine (NECA)-induced glucose production in primary cultured rat hepatocytes. The m-primary benzamide derivative 15f was the most potent compound (IC(50)=0.017 microM), being 15-fold more active than the corresponding 9-methyl derivative (1). Compound 15f showed 72- and 5.2-fold selectivity for human A(2B) receptor versus human A(1) and A(2A) receptors, respectively. Structure-activity relationship (SAR) studies of the synthesized compounds indicated that a three-carbon linker, fixed in the form of a benzene ring, between the adenine core and the amide moiety is important for both A(2B) antagonistic activity and selectivity. The IC(50) values in rat hepatocyte glucose assay correlated well with the IC(50) values in cAMP assay using Chinese hamster ovary cells stably transfected with human A(2B) receptors (r(2)=0.94). The A(1) and A(2A) affinities showed no correlation with the potency to inhibit NECA-induced glucose production. These results strongly support our previous conclusion that adenosine agonist-induced hepatic glucose production in rat hepatocytes is mediated through the A(2B) receptor.


Journal of Medicinal Chemistry | 2001

2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists : Their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A2B receptor

Hitoshi Harada; Osamu Asano; Yorihisa Hoshino; Seiji Yoshikawa; Masayuki Matsukura; Yasuhiro Kabasawa; Jun Niijima; Yoshihiko Kotake; Nobuhisa Watanabe; Tsutomu Kawata; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Hiroe Minami; Kaya Nagata; Manabu Murakami; Junsaku Nagaoka; Seiichi Kobayashi; Isao Tanaka; Shinya Abe


Archive | 1998

Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes

Osamu Asano; Hitoshi Harada; Yorihisa Hoshino; Seiji Yoshikawa; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Kaya Nagata; Junsaku Nagaoka; Manabu Murakami; Seiichi Kobayashi


European Journal of Pharmacology | 2003

Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes

Nobuyuki Yasuda; Takashi Inoue; Tatsuo Horizoe; Kaya Nagata; Hiroe Minami; Tsutomu Kawata; Yorihisa Hoshino; Hitoshi Harada; Seiji Yoshikawa; Osamu Asano; Junsaku Nagaoka; Manabu Murakami; Shinya Abe; Seiichi Kobayashi; Isao Tanaka


Archive | 2000

Fused imidazole compounds and remedies for diabetes mellitus

Hiroshi Akamatsu; Osamu Asano; Toyokazu Haga; Hitoshi Harada; Kenji Hayashi; Tatsuo Horizoe; Takashi Inoue; Tsutomu Kawata; Seiichi Kobayashi; Hiroe Minami; Manabu Murakami; Junsaku Nagaoka; Toshihiko Naito; Shigeto Negi; Kaya Ohashi; Naoki Ozeki; Toshikazu Shimizu; Naoyuki Shimomura; Isao Tanaka; Nobuhisa Watanabe; Nobuyuki Yasuda; Seiji Yoshikawa


Archive | 2000

Condensed imidazole compounds and a therapeutic agent for diabetes mellitus

Osamu Asano; Hitoshi Harada; Seiji Yoshikawa; Nobuhisa Watanabe; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Kaya Ohashi; Hiroe Minami; Junsaku Nagaoka; Manabu Murakami; Seiichi Kobayashi; Isao Tanaka; Tsutomu Kawata; Naoyuki Shimomura; Hiroshi Akamatsu; Naoki Ozeki; Toshikazu Shimizu; Kenji Hayashi; Toyokazu Haga; Shigeto Negi; Toshihiko Naito


Archive | 1998

PURINE DERIVATIVE AND ADENOSINE A2 RECEPTOR ANTAGONIST AS AGENT FOR PREVENTING AND TREATING DIABETES

Osamu Asano; Hitoshi Harada; Tatsuhisa Horizoe; Takehisa Hoshino; Takashi Inoue; Seiichi Kobayashi; Manabu Murakami; Junsaku Nagaoka; Kaya Osada; Nobuyuki Yasuda; Seiji Yoshikawa; 敬 井上; 均 原田; 誠二 吉川; 達央 堀添; 信之 安田; 精一 小林; 偉久 星野; 学 村上; 淳作 永岡; 修 浅野; 香弥 長田


Archive | 1998

Purine compounds and adenosine A2 receptor antagonist as preventive or therapeutic agent for diabetes mellitus

Osamu Asano; Hitoshi Harada; Tatsuo Horizoe; Yorihisa Hoshino; Takashi Inoue; Seiichi Kobayashi; Manabu Murakami; Junsaku Nagaoka; Kaya Nagata; Nobuyuki Yasuda; Seiji Yoshikawa


Archive | 1989

Glycerin derivative and its pharmacological use

Kazuo Okano; Osamu Asano; Naoyuki Shimomura; Tetsuya Kawahara; Shinya Abe; Shuhei Miyazawa; Mitsuaki Miyamoto; Hiroyuki Yoshimura; Koukichi Harada; Junsaku Nagaoka; Tsutomu Kawata; Tsutomu Yoshimura; Hiromasa Suzuki; Shigeru Souda; Yoshimasa Machida; Kouichi Katayama; Isao Yamatsu


Archive | 1990

Guanidinobenzoic ester derivative

Shigeru Souda; Naoyuki Shimomura; Norihiro Ueda; Shuhei Miyazawa; Takashi Yamanaka; Kaname Miyamoto; Ieharu Hishinuma; Junichi Nagakawa; Naoko Nagaoka; Hidetoshi Kawashima; Tsutomu Kawata; Junsaku Nagaoka; Tsuneo Wakabayashi

Collaboration


Dive into the Junsaku Nagaoka's collaboration.

Researchain Logo
Decentralizing Knowledge